Common Equity: The sum of all common equity items.
9 Meters Biopharma, Inc. (MNTRQ) had Common Equity of $2.40M for the most recently reported fiscal year, ending 2022-12-31.
| Income Statement Financials | |
-- |
|
$-43.77M |
|
-- |
|
-- |
|
$42.02M |
|
$-42.02M |
|
$-1.75M |
|
$-43.77M |
|
$-43.77M |
|
$-43.77M |
|
$-43.77M |
|
$-43.77M |
|
$-43.77M |
|
$-42.02M |
|
$-40.18M |
|
12.96M |
|
12.96M |
|
$-3.38 |
|
$-3.38 |
|
| Balance Sheet Financials | |
$33.02M |
|
$0.01M |
|
$0.13M |
|
$33.15M |
|
$30.70M |
|
-- |
|
$0.05M |
|
$30.75M |
|
|
Common Equity |
$2.40M |
$2.40M |
|
$2.40M |
|
13.04M |
|
| Cash Flow Statement Financials | |
$-37.24M |
|
$-0.00M |
|
$19.91M |
|
$46.99M |
|
$29.66M |
|
$-17.33M |
|
$3.94M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.08 |
|
-- |
|
-- |
|
-- |
|
8.17 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-37.25M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-1823.20% |
|
-1823.19% |
|
-132.03% |
|
-1823.19% |
|
$0.18 |
|
$-2.87 |
|
$-2.87 |
|